Medical Education Library

Managing High-Risk Patients With Acute Coronary Syndrome


A supplement to Cardiology News. This supplement was sponsored by Merck.
Written by Paul Cerrato, Medical Writer


• Acute coronary syndrome
• Acute myocardial infarction
• GP IIb/IIIa inhibitors
• Eptifibatide
• Cardiology
• percutaneous coronary intervention

Faculty/Faculty Disclosures

Marc Cohen, MD, FACC
Division of Cardiology
Newark Beth Israel
Medical Center
Newark, New Jersey
Professor of Medicine
Mount Sinai School
of Medicine
New York, New York

Dr Cohen has disclosed that he has served as an advisor or consultant for Bristol-Myers Squibb, Datascope, and sanofi-aventis; has received grant/research support from Bristol-Myers Squibb, Cordis, and Datascope; and has served as a speaker or a member of a speakers bureau for Bristol-Myers Squibb, Merck, and sanofi-aventis.

To view the supplement, click the image above.

Recommended Reading

EMA: No Cancer Link for ARBs
MDedge Cardiology
CMS Issues Final Rule on Accountable Care Organizations
MDedge Cardiology
Measuring Quality of Care
MDedge Cardiology
ACO Details Are Out: The Policy & Practice Podcast
MDedge Cardiology
FDA Updates Safety Review of Varenicline
MDedge Cardiology
Influenza Vaccine's Efficacy Far From Perfect
MDedge Cardiology
ACE Inhibitors May Prevent Bone Loss in Men
MDedge Cardiology
Antiplatelet Therapy: Role of Effient (prasugrel)
MDedge Cardiology
An Approach to the Management of Type 2 Diabetes Mellitus in Patients Receiving Add-On Therapy With Colesevelam HCl
MDedge Cardiology
Clinical Perspectives in Pulmonary Arterial Hypertension
MDedge Cardiology